Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Merseburger

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Aktuelle Urologie|August 3, 2022
Axel Merseburger
Aktuelle Urologie|April 6, 2021
Axel Merseburger
Aktuelle Urologie|November 24, 2020
[Prostate cancer - where is the journey going?]Axel Merseburger
Urologie (Heidelberg, Germany)|December 6, 2023
[Metastatic castration-resistant prostate cancer: practical guidance for personalized decision-making]Boris Hadaschik, Axel Merseburger
Aktuelle Urologie|January 25, 2022
Axel Merseburger, Hubert Kübler, Stephan Roth
Aktuelle Urologie|November 27, 2019
Chizoba Linda Weber, Michael Schneider, Axel Merseburger
Der Urologe. Ausg. A|July 2, 2021
[Cardiovascular side effects in patients undergoing androgen deprivation therapy: superiority of gonadotropin-releasing hormone antagonists? An update]Gunhild von Amsberg, Holger Thiele, Axel Merseburger
World Journal of Urology|September 24, 2018
New study suggests patients with advanced prostate cancer on androgen deprivation therapy need more dialogue with health care provider, especially around cardiovascular riskAxel Merseburger, Anne Bro Falkenberg, Olga J Kornilova
European Urology|May 28, 2013
Castration-resistant prostate cancer: where we stand in 2013 and what urologists should knowAxel Heidenreich, David Pfister, Axel Merseburger, et al.
Aktuelle Urologie|March 28, 2018
[Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma]Kurt Miller, Jürgen E Gschwend, Axel Merseburger, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Aktuelle Urologie|August 3, 2022
Axel Merseburger
Aktuelle Urologie|April 6, 2021
Axel Merseburger
Aktuelle Urologie|November 24, 2020
[Prostate cancer - where is the journey going?]Axel Merseburger
Urologie (Heidelberg, Germany)|December 6, 2023
[Metastatic castration-resistant prostate cancer: practical guidance for personalized decision-making]Boris Hadaschik, Axel Merseburger
Aktuelle Urologie|January 25, 2022
Axel Merseburger, Hubert Kübler, Stephan Roth
Aktuelle Urologie|November 27, 2019
Chizoba Linda Weber, Michael Schneider, Axel Merseburger
Der Urologe. Ausg. A|July 2, 2021
[Cardiovascular side effects in patients undergoing androgen deprivation therapy: superiority of gonadotropin-releasing hormone antagonists? An update]Gunhild von Amsberg, Holger Thiele, Axel Merseburger
World Journal of Urology|September 24, 2018
New study suggests patients with advanced prostate cancer on androgen deprivation therapy need more dialogue with health care provider, especially around cardiovascular riskAxel Merseburger, Anne Bro Falkenberg, Olga J Kornilova
European Urology|May 28, 2013
Castration-resistant prostate cancer: where we stand in 2013 and what urologists should knowAxel Heidenreich, David Pfister, Axel Merseburger, et al.
Aktuelle Urologie|March 28, 2018
[Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma]Kurt Miller, Jürgen E Gschwend, Axel Merseburger, et al.
Pageof 4